Obesity in acute ischaemic stroke patients treated with intravenous thrombolysis therapy.

Neurological Research
Hongmin LiMengzhou Xue

Abstract

Objectives: This article aimed to analyze the relationship between obesity and the efficacy of acute ischaemic stroke patients treated with IVT.Background: Stroke causes morbidity and mortality in large numbers of individuals annually. Intravenous thrombolysis (IVT)with recombinant tissue plasminogen activator (r-tPA) is currently the only approved by the FDA for treatment of acute ischaemic stroke. Researchers have focused on studying the mechanisms associated with ischaemic stroke. Obesity is an established vascular risk factor with increasing prevalence and a huge impact on public health worldwide. It is an independent predictor for ischaemic stroke with a 4% risk increase for each unit augmentation in body mass index (BMI). Therefore, obese patients will constitute an increasing subgroup of candidates for IVT. However, its impact on prognosis in acute ischaemic stroke patients with intravenous thrombolysis did not reach a consensus conclusion.Methods: Systematic literature search of PUBMED databases published before August 2020, was performed to identify studies addressing the role of obesity in acute ischaemic stroke patients treated with IVT. Studies included randomized clinical trials, observational studies, guideline st...Continue Reading

References

Apr 1, 1992·Stroke; a Journal of Cerebral Circulation·S G TimsitD B Hier
Apr 6, 2006·JAMA : the Journal of the American Medical Association·Cynthia L OgdenKatherine M Flegal
May 23, 2006·Lancet Neurology·Jeffrey A SwitzerRobert J Adams
Aug 22, 2006·Expert Review of Cardiovascular Therapy·L Romayne KurukulasuriyaJames Sowers
Jul 13, 2007·European Heart Journal·Abel Romero-CorralFrancisco Lopez-Jimenez
Feb 27, 2010·Annals of Neurology·Lydia A BazzanoJiang He
Jul 7, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·I SaitoS Tsugane
May 24, 2011·Maturitas·Niki KatsikiKonstantinos Vemmos
Jul 16, 2011·Stroke; a Journal of Cerebral Circulation·Hakan SarikayaRalf W Baumgartner
Oct 1, 2011·Stroke; a Journal of Cerebral Circulation·Bruce OvbiageleHans-Christoph Diener
May 15, 2012·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Raymond C S SeetAlejandro A Rabinstein
Aug 17, 2012·Neurology·Beom Joon KimUNKNOWN For Korean Stroke Registry investigators
Sep 22, 2012·Annals of the New York Academy of Sciences·Etsuro Mori
May 9, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Bruce C V CampbellUNKNOWN EPITHET Investigators
Jul 19, 2013·European Neurology·Erwin ChiqueteCarlos Cantú-Brito
Dec 25, 2013·Handbook of Clinical Neurology·Harold P Adams
Jan 17, 2014·The New England Journal of Medicine·Deirdre K TobiasFrank B Hu
Jun 3, 2014·JAMA Neurology·Christian DehlendorffTom S Olsen
Dec 3, 2014·Clinical Neurology and Neurosurgery·Adrià ArboixJoan Massons
Jan 31, 2015·International Journal of Stroke : Official Journal of the International Stroke Society·Klaus Kaae Andersen, Tom Skyhøj Olsen
Apr 16, 2016·The American Journal of the Medical Sciences·Rong ChenWuwei Feng
May 14, 2016·Cerebrovascular Diseases·Anastasios ChatzikonstantinouMarc E Wolf
Jul 2, 2016·Expert Review of Hematology·Adrià ArboixCarles Besses
Aug 2, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H GensickeUNKNOWN Thrombolysis in Stroke Patients (TriSP) collaborators
Dec 14, 2016·Frontiers of Neurology and Neuroscience·Jong S Kim, Louis R Caplan
Jan 26, 2017·Reviews in the Neurosciences·Jitender GairollaDheeraj Khurana
Feb 6, 2017·Circulation Research·Hooman Kamel, Jeff S Healey
May 24, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gino Seravalle, Guido Grassi
Jun 24, 2017·Therapeutic Advances in Cardiovascular Disease·Yogita RochlaniJawahar L Mehta
Aug 2, 2017·Seminars in Neurology·Xian Nan TangAmytis Towfighi
Sep 14, 2017·The New England Journal of Medicine·Lars SøndergaardUNKNOWN Gore REDUCE Clinical Study Investigators
Dec 17, 2017·Journal of the Neurological Sciences·Demet Funda Bas, Atilla Ozcan Ozdemir
Dec 24, 2017·Neuropharmacology·Raj N Kalaria
Mar 17, 2018·Journal of the American College of Cardiology·Pil Hyung LeeSeung-Jung Park
Apr 24, 2018·Journal of Neurology·Bruno MirandaJosé M Ferro
Jun 14, 2018·Clinical Science·Allison B ReissJoshua DeLeon
Aug 5, 2018·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Shahram MajidiAdnan I Qureshi
Sep 1, 2018·JAMA Neurology·Robert W RegenhardtLouis R Caplan
Sep 27, 2018·Metabolism: Clinical and Experimental·Habib YaribeygiAmirhossein Sahebkar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of the Royal College of Physicians of Edinburgh
G A Ford, Peter Sandercock
VASA. Zeitschrift für Gefässkrankheiten
Naz AhmedGeorge A Antoniou
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Björn ReuterStroke Working Group of Baden-Wuerttemberg
© 2021 Meta ULC. All rights reserved